Preliminary Results from a Prospective Study of Inetetamab in Combination with Pyrotinib and Utidelone for HER2-positive Metastatic Breast Cancer (Iputrial)
ANNALS OF ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2023)